The Incidence of Occult Hepatitis C Virus Infection in Hemodialysed Patients With Liver Enzymes Disturbances

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01054664

Enrollment

Registered

2010-01-22

Start date

2010-02-28

Completion date

Unknown

Last updated

2010-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysed Patients With Impaired Liver Enzymes

Keywords

liver enzymes, peripheral mononuclear blood cells, hemodialysis, hepatitis C, RNA

Brief summary

To assess the incidence of occult hepatitis C virus in hemodialysed patients with mild impairment of liver enzymes

Detailed description

occult hepatitis C virus will be checked in monocytes of hemodialyzed patients with permanent mild impairment of liver enzymes This population has no evidence of hepatitis B or C according to standard laboratory tests (HVC antibodies,HCV PCR, hepatitis B antibodies) Hepatitis C virus RNA will be performed in peripheral blood mononuclear cells of hemodialysed patients

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Hemodialysed patients with impaired liver enzymes

Exclusion criteria

* hepatitis B and C positive

Countries

Israel

Contacts

Primary ContactEleonora Plotkin, MD

nora.plotkin@clalit.org.il972 9 7472517

Outcome results